| | CD3+T-cell counts | CD4+T-cell counts | CD8+T-cell counts | CD4+/CD8+ ratio | CD3+ decreased group (n = 157) | CD3+ nondecreased group (n = 49) | value | CD4+ decreased group (n = 158) | CD4+ nondecreased group (n = 48) | value | CD8+ decreased group (n = 131) | CD8+ nondecreased group (n = 75) | value | CD4+/CD8+ nondecreased group (n = 161) | CD4+/CD8+ decreased group (n = 45) | value |
| Age, mean ± SD, years | 63.53 ± 15.82 | 57.61 ± 16.15 | 0.02 | 63.73 ± 15.62 | 56.85 ± 16.53 | 0.01 | 64.06 ± 15.64 | 58.75 ± 16.33 | 0.02 | 62.18 ± 15.44 | 61.91 ± 18.30 | 0.91 | Length of ICU stay, median, [IQR], d | 11.00 (4.5, 21.0) | 7.00 (4.0, 17.0) | 0.03 | 8 (4, 14) | 8.00 (4.00, 13.0) | 0.88 | 7 (4.0, 14.0) | 9.00 (5.0, 18.0) | 0.12 | 8.0 (4.0, 15.0) | 8.0 (4.0, 19.0) | 0.69 | APACHE II score, mean ± SD | 16.90 ± 6.83 | 14.39 ± 5.62 | 0.01 | 16.72 ± 6.65 | 14.92 ± 6.47 | 0.10 | 17.05 ± 6.61 | 15.00 ± 6.51 | 0.03 | 16.31 ± 6.65 | 16.27 ± 6.65 | 0.96 | SOFA score, median, [IQR] | 7.00 (4.00, 9.00) | 6.00 (4.00, 9.00) | 0.88 | 6.00 (4.00, 10.00) | 6.00 (3.00, 9.00) | 0.13 | 6.00 (4.00, 9.00) | 6.00 (4.00, 10.00) | 0.92 | 6.00 (4.00, 9.00) | 7.00 (5.00, 10.00) | 0.11 | Shock, n (%) | 82 (52.22%) | 22 (44.89%) | 0.73 | 81 (51.27%) | 23 (47.92%) | 0.74 | 60 (45.8%) | 44 (58.7%) | 0.08 | 79 (49.1%) | 25 (55.6%) | 0.50 | MV, n (%) | 102 (67.5%) | 25 (51.0%) | 0.04 | 96 (61.39%) | 31 (64.58%) | 0.73 | 81 (61.8%) | 46 (61.3%) | 1.0 | 63 (60.9%) | 29 (64.4%) | 0.73 | ICU mortality, n (%) | 29 (18.47%) | 6 (12.24%) | 0.34 | 25 (15.82%) | 10 (20.83%) | 0.84 | 26 (19.8%) | 9 (12.0%) | 0.18 | 27 (16.8%) | 8 (17.8%) | 0.82 | 28-day mortality, n (%) | 45 (28.66%) | 11 (22.45%) | 0.39 | 43 (27.21%) | 13 (27.08%) | 0.99 | 40 (30.5%) | 16 (45.7%) | 0.11 | 41 (25.5%) | 15 (33.3%) | 0.29 | 1-year mortality, n (%) | 65 (41.4%) | 17 (34.7%) | 0.50 | 63 (39.9%) | 19 (39.6%) | 0.97 | 53 (40.5%) | 29 (38.7%) | 0.88 | 59 (36.6%) | 23 (51.1%) | 0.09 | 3-year survival, n (%) | 76 (47.8%) | 26 (53.1%) | 0.62 | 76 (48.1%) | 25 (52.1%) | 0.38 | 62 (47.3%) | 39 (52.0%) | 0.31 | 86 (53.4%) | 15 (33.3%) | 0.01 |
|
|
SD, standard deviation; APACHE, acute physiology and chronic health evaluation; IQR, interquartile range; MV, mechanical ventilation.
|